Jupiter Research Capital (Asia) Ltd’s Cullinan Therapeutics CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$360K Buy
+23,474
New +$449K 0.04% 436

Other funds holding CGEM

Jupiter Research Capital (Asia) Ltd's CGEM Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd opened a new position in Cullinan Therapeutics (CGEM) in Q3 2026: 23,474 shares worth $360K. The stake represents 0.04% of the portfolio and ranks #436 among its holdings.

175 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 23,474 shares of Cullinan Therapeutics worth $360K as of Q3 2026.
  • Cullinan Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
  • Cullinan Therapeutics made up 0.04% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #436 holding.
  • 175 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.